Sacubitril And Valsartan Tablet, Film Coated
NDC Package 70377-032-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Sacubitril And Valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. This formulation utilizes a tablet, film coated delivery system. Marketed by Biocon Pharma Inc., this product is identified by NDC 70377-032 and is authorized under FDA application ANDA213680.

Identification & Billing

NDC Package Code
70377-032-11
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
70377-032
11-Digit Billing Format
70377003211
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Sacubitril And Valsartan
Non-Proprietary Name
Sacubitril And Valsartan
Substance Name
Sacubitril; Valsartan
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Sacubitril and valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal.LVEF is a variable measure, so use clinical judgment in deciding whom to treat [see Clinical Studies (14.1)].

Regulatory & Marketing

Labeler Name
Biocon Pharma Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA213680
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-17-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70377-032). Click a package code to view its specific billing and regulatory data.

70377-032-12
60 TABLET, FILM COATED in 1 BOTTLE
70377-032-13
180 TABLET, FILM COATED in 1 BOTTLE
70377-032-14
500 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70377-032-11 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Sacubitril And Valsartan, a human prescription drug labeled by Biocon Pharma Inc.. This tablet, film coated is formulated for oral use and contains sacubitril; valsartan as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biocon Pharma Inc. on July 17, 2025. The current certification is valid through December 31, 2026.

How is this Biocon Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70377003211. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70377-032-11
11-Digit CMS (5-4-2)
70377-0032-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.